tiprankstipranks
Haemonetics Announces Definitive Agreement to Acquire Attune Medical
PremiumPress ReleasesHaemonetics Announces Definitive Agreement to Acquire Attune Medical
2M ago
Haemonetics to acquire Attune Medical for $160M upfront, sees accretion
PremiumThe Fly
Haemonetics to acquire Attune Medical for $160M upfront, sees accretion
2M ago
Haemonetics raises FY24 adjusted EPS view to $3.90-$4.00 from $3.75-$3.95
PremiumThe Fly
Haemonetics raises FY24 adjusted EPS view to $3.90-$4.00 from $3.75-$3.95
3M ago
Citi entering 2024 ‘cautiously optimistic’ on U.S. MedTech companies
PremiumThe FlyCiti entering 2024 ‘cautiously optimistic’ on U.S. MedTech companies
5M ago
Needham medtech analysts hold analyst/industry conference call
PremiumThe Fly
Needham medtech analysts hold analyst/industry conference call
5M ago
Needham medtech analysts hold analyst/industry conference call
PremiumThe Fly
Needham medtech analysts hold analyst/industry conference call
5M ago
Haemonetics raises FY24 adjusted EPS view to $3.75-$3.95 from $3.60-$3.90
PremiumThe FlyHaemonetics raises FY24 adjusted EPS view to $3.75-$3.95 from $3.60-$3.90
6M ago
Haemonetics reports Q2 adjusted EPS 99c, consensus 89c
PremiumThe Fly
Haemonetics reports Q2 adjusted EPS 99c, consensus 89c
6M ago
Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
PremiumPress Releases
Haemonetics 2nd Quarter Fiscal Year 2024 Earnings Release Available on Investor Relations Website
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100